Pulmonx Corporation LUNG Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pulmonx Corporation's stock issuance proceeds?
- Pulmonx Corporation (LUNG) reported stock issuance proceeds of $40K in Q1 2026.
- How has Pulmonx Corporation's stock issuance proceeds changed year-over-year?
- Pulmonx Corporation's stock issuance proceeds decreased by 63.6% year-over-year, from $110K to $40K.
- What is the long-term trend for Pulmonx Corporation's stock issuance proceeds?
- Over 4 years (2021 to 2025), Pulmonx Corporation's stock issuance proceeds has grown at a -39.6% compound annual growth rate (CAGR), from $1.87M to $249K.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.